Invention Grant
- Patent Title: Anti-CD3 antibody and pharmaceutical composition for cancer treatment comprising same
-
Application No.: US16754431Application Date: 2018-10-22
-
Publication No.: US11498965B2Publication Date: 2022-11-15
- Inventor: Ki Su Kim , Jun Hong Jeong , Ae Rin Yoon , Eun Jung Song , Hye Ji Choi , Ok Jae Lim , Yun Jung Lee , Hyung Kwon Lim , Jong Wha Won
- Applicant: GREEN CROSS CORPORATION , MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
- Applicant Address: KR Yongin-si; KR Yongin-si
- Assignee: GREEN CROSS CORPORATION,MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
- Current Assignee: GREEN CROSS CORPORATION,MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
- Current Assignee Address: KR Yongin-si; KR Yongin-si
- Agency: Sughrue Mion, PLLC
- Priority: KR10-2017-0136564 20171020
- International Application: PCT/KR2018/012492 WO 20181022
- International Announcement: WO2019/078697 WO 20190425
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
The present invention relates to an anti-CD3 antibody and a pharmaceutical composition for cancer treatment comprising same. The antibody according to the present invention has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.
Public/Granted literature
- US20200317779A1 ANTI-CD3 ANTIBODY AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING SAME Public/Granted day:2020-10-08
Information query
